| Product Code: ETC4759237 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Vaccines Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Vaccines Market - Industry Life Cycle |
3.4 Serbia Vaccines Market - Porter's Five Forces |
3.5 Serbia Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Serbia Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Serbia Vaccines Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Serbia Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Serbia Vaccines Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
4 Serbia Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives to promote vaccination programs |
4.2.2 Growing awareness about the importance of vaccines in preventing diseases |
4.2.3 Rising prevalence of infectious diseases in Serbia |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas |
4.3.2 High costs associated with vaccine development and distribution |
5 Serbia Vaccines Market Trends |
6 Serbia Vaccines Market Segmentations |
6.1 Serbia Vaccines Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Serbia Vaccines Market Revenues & Volume, By Conjugate vaccines, 2021-2031F |
6.1.3 Serbia Vaccines Market Revenues & Volume, By Inactivated and subunit vaccines, 2021-2031F |
6.1.4 Serbia Vaccines Market Revenues & Volume, By Live attenuated vaccines, 2021-2031F |
6.1.5 Serbia Vaccines Market Revenues & Volume, By Recombinant vaccines, 2021-2031F |
6.1.6 Serbia Vaccines Market Revenues & Volume, By Toxoid vaccines, 2021-2031F |
6.2 Serbia Vaccines Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Serbia Vaccines Market Revenues & Volume, By Monovalent vaccines, 2021-2031F |
6.2.3 Serbia Vaccines Market Revenues & Volume, By Multivalent vaccines, 2021-2031F |
6.3 Serbia Vaccines Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Serbia Vaccines Market Revenues & Volume, By Pneumococcal disease, 2021-2031F |
6.3.3 Serbia Vaccines Market Revenues & Volume, By DTP, 2021-2031F |
6.3.4 Serbia Vaccines Market Revenues & Volume, By Influenza, 2021-2031F |
6.3.5 Serbia Vaccines Market Revenues & Volume, By HPV, 2021-2031F |
6.3.6 Serbia Vaccines Market Revenues & Volume, By Meningococcal disease, 2021-2031F |
6.3.7 Serbia Vaccines Market Revenues & Volume, By Polio, 2021-2031F |
6.3.8 Serbia Vaccines Market Revenues & Volume, By Other disease indications, 2021-2031F |
6.3.9 Serbia Vaccines Market Revenues & Volume, By Other disease indications, 2021-2031F |
6.4 Serbia Vaccines Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Serbia Vaccines Market Revenues & Volume, By Intramuscular and subcutaneous administration, 2021-2031F |
6.4.3 Serbia Vaccines Market Revenues & Volume, By Oral administration, 2021-2031F |
6.4.4 Serbia Vaccines Market Revenues & Volume, By Other routes of administration, 2021-2031F |
6.5 Serbia Vaccines Market, By Patient Type |
6.5.1 Overview and Analysis |
6.5.2 Serbia Vaccines Market Revenues & Volume, By Pediatric patients, 2021-2031F |
6.5.3 Serbia Vaccines Market Revenues & Volume, By Adult patients, 2021-2031F |
7 Serbia Vaccines Market Import-Export Trade Statistics |
7.1 Serbia Vaccines Market Export to Major Countries |
7.2 Serbia Vaccines Market Imports from Major Countries |
8 Serbia Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rate |
8.2 Number of vaccination campaigns conducted annually |
8.3 Percentage of population vaccinated against common diseases |
9 Serbia Vaccines Market - Opportunity Assessment |
9.1 Serbia Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Serbia Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Serbia Vaccines Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Serbia Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Serbia Vaccines Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
10 Serbia Vaccines Market - Competitive Landscape |
10.1 Serbia Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Serbia Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here